Characterization of the GHB Withdrawal Syndrome [PDF]
The gamma-hydroxybutyric acid (GHB) withdrawal syndrome can have a fulminant course, complicated by severe complications such as delirium or seizures. Detoxification by tapering with pharmaceutical GHB is a safe way to manage GHB withdrawal. However, a detailed description of the course of the GHB withdrawal syndrome is currently lacking.
Wolf, C.J.H. +9 more
openaire +5 more sources
Rasagiline Withdrawal Syndrome in Parkinson’s Disease
Parkinson’s disease (PD) patients using dopamine agonists can develop withdrawal symptoms, referred to as dopamine agonist withdrawal syndrome (DAWS), under dose tapering or discontinuation of these drugs.
Paolo Solla +10 more
doaj +2 more sources
Management of Tizanidine Withdrawal Syndrome: A Case Report [PDF]
Most drugs that act on the central nervous system (CNS) require dose titration to avoid withdrawal syndrome. Tizanidine withdrawal syndrome is caused by adrenergic discharge due to its α 2 -agonist mechanism and is characterized by hypertension, reflex ...
A Suárez-Lledó +5 more
doaj +3 more sources
VENLAFAXINE WITHDRAWAL SYNDROME [PDF]
Dual-action antidepressants serotonin-norepinephrine reuptake inhibitors (SRNIs) are widely used to treat depression. Owing to its efficiency and safety, venlafaxine holds a prominent place in this group of depressants. Abrupt venlafaxine discontinuation involves a high risk of withdrawal syndrome.
Sabljić, Vladimir +2 more
core +7 more sources
Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome
Glucocorticoid withdrawal syndrome is a challenging clinical phenomenon that can complicate the postsurgical recovery of Cushing syndrome. It is characterized by physical tolerance and dependence to supraphysiologic glucocorticoid exposure during active ...
Catherine D. Zhang +2 more
doaj +3 more sources
Two newborns of heroin-addicted mothers suffering neonatal withdrawal syndrome [PDF]
Neonatal withdrawal syndrome is characterized by non-specific signs and symptoms that occur in infants following in-utero drug exposure. The incidence of neonatal withdrawal syndrome is 16-90% in infants of mothers abusing heroin.
Eren Kale-Çekinmez +7 more
doaj +2 more sources
Maternal methadone use in pregnancy : factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources [PDF]
The objectives of this study were to investigate factors associated with the development of neonatal abstinence syndrome (NAS) and to assess the implications for healthcare resources of infants born to drug-misusing women. Design.
Dryden, C +11 more
core +4 more sources
Cognitive-behavioural therapy (CBT) approaches have among the highest level of empirical support for drug and alcohol use disorder treatment. The unbearable impact of withdrawal syndrome such as physical related problems, psychological, social and ...
Khirza Maulida Fitri +1 more
doaj +1 more source
Topical steroid withdrawal syndrome in a mother and son: A case report
Topical corticosteroids are first-line treatment for many dermatoses, and are generally considered safe and effective. However, topical steroid withdrawal syndrome can result from use of topical corticosteroids, and this condition is not well-known among
Aileen M Feschuk, Michelle E Pratt
doaj +1 more source
Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department. [PDF]
BACKGROUND Cannabis-related medical consultations are increasing worldwide, a non-negligible public health issue; patients presenting to acute care traditionally complain of abdominal pain and vomiting.
Exadaktylos, Aristomenis K. +5 more
core +2 more sources

